| Year |
Citation |
Score |
| 2020 |
Zhang X, Braun U, Harneit A, Zang Z, Geiger LS, Betzel RF, Chen J, Schweiger JI, Schwarz K, Reinwald JR, Fritze S, Witt S, Rietschel M, Nöthen MM, Degenhardt F, ... Schwarz E, et al. Generative network models of altered structural brain connectivity in schizophrenia. Neuroimage. 117510. PMID 33160087 DOI: 10.1016/j.neuroimage.2020.117510 |
0.319 |
|
| 2020 |
Chen J, Cao H, Kaufmann T, Westlye LT, Tost H, Meyer-Lindenberg A, Schwarz E. Identification of Reproducible BCL11A Alterations in Schizophrenia Through Individual-Level Prediction of Coexpression. Schizophrenia Bulletin. PMID 32232389 DOI: 10.1093/Schbul/Sbaa047 |
0.308 |
|
| 2020 |
Chen J, Zang Z, Braun U, Schwarz K, Harneit A, Kremer T, Ma R, Schweiger J, Moessnang C, Geiger L, Cao H, Degenhardt F, Nöthen MM, Tost H, Meyer-Lindenberg A, ... Schwarz E, et al. Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function. Jama Psychiatry. PMID 32049268 DOI: 10.1001/Jamapsychiatry.2019.4792 |
0.355 |
|
| 2019 |
Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, ... ... Schwarz E, et al. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. Jama Psychiatry. PMID 30969333 DOI: 10.1001/jamapsychiatry.2019.0257 |
0.301 |
|
| 2019 |
Schwarz E, Doan NT, Pergola G, Westlye LT, Kaufmann T, Wolfers T, Brecheisen R, Quarto T, Ing AJ, Carlo PD, Gurholt TP, Harms RL, Noirhomme Q, Moberget T, Agartz I, et al. Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder. Translational Psychiatry. 9: 12. PMID 30664633 DOI: 10.1038/S41398-018-0225-4 |
0.341 |
|
| 2018 |
Chen J, Cao H, Meyer-Lindenberg A, Schwarz E. Male increase in brain gene expression variability is linked to genetic risk for schizophrenia. Translational Psychiatry. 8: 140. PMID 30068996 DOI: 10.1038/s41398-018-0200-0 |
0.314 |
|
| 2018 |
Alnaes D, Kaufmann T, Palomera AC, Schwarz E, Meer Dvd, Moberget T, Rokicki J, Doan NT, Brandt CL, Haatveit BC, Lund MJ, Melle I, Agartz I, Jönsson EG, Pergola G, et al. S193. Brain Variability in Schizophrenia Spectrum Disorder Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1085 |
0.428 |
|
| 2017 |
Cao H, Chen J, Meyer-Lindenberg A, Schwarz E. A polygenic score for schizophrenia predicts glycemic control. Translational Psychiatry. 7: 1295. PMID 29249829 DOI: 10.1038/s41398-017-0044-z |
0.319 |
|
| 2017 |
Schwarz E. A gene-based review of RGS4 as a putative risk gene for psychiatric illness. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 177: 267-273. PMID 28544755 DOI: 10.1002/ajmg.b.32547 |
0.332 |
|
| 2017 |
Schwarz E, Maukonen J, Hyytiäinen T, Kieseppä T, Orešič M, Sabunciyan S, Mantere O, Saarela M, Yolken R, Suvisaari J. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophrenia Research. PMID 28442250 DOI: 10.1016/J.Schres.2017.04.017 |
0.351 |
|
| 2016 |
Reuter AR, Bumb JM, Mueller JK, Rohleder C, Pahlisch F, Hanke F, Arens E, Leweke FM, Koethe D, Schwarz E. Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-17. PMID 27734750 DOI: 10.1080/15622975.2016.1246750 |
0.371 |
|
| 2016 |
Frangou S, Schwarz E, Meyer-Lindenberg A. Identifying multimodal signatures associated with symptom clusters: the example of the IMAGEMEND project. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 15: 179-80. PMID 27265711 DOI: 10.1002/Wps.20334 |
0.435 |
|
| 2016 |
Schwarz E, Izmailov R, Liò P, Meyer-Lindenberg A. Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function. Schizophrenia Bulletin. PMID 27056717 DOI: 10.1093/schbul/sbw035 |
0.342 |
|
| 2016 |
Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJ, Arias-Vasquez A, Smoller JW, Nichols TE, Neale MC, McIntosh AM, Lee P, McMahon FJ, Meyer-Lindenberg A, Mattheisen M, ... ... Schwarz E, et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nature Neuroscience. PMID 26854805 DOI: 10.1038/Nn.4228 |
0.43 |
|
| 2015 |
Tomasik J, Schwarz E, Lago SG, Rothermundt M, Leweke FM, van Beveren NJ, Guest PC, Rahmoune H, Steiner J, Bahn S. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients. Brain, Behavior, and Immunity. PMID 26541453 DOI: 10.1016/J.Bbi.2015.10.019 |
0.417 |
|
| 2015 |
Severance EG, Gressitt KL, Alaedini A, Rohleder C, Enning F, Bumb JM, Müller JK, Schwarz E, Yolken RH, Leweke FM. IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. Brain, Behavior, and Immunity. 44: 148-58. PMID 25241021 DOI: 10.1016/J.Bbi.2014.09.009 |
0.369 |
|
| 2015 |
Schwarz E, Steiner J, Guest PC, Bogerts B, Bahn S. Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 16: 22-30. PMID 24001020 DOI: 10.3109/15622975.2013.817685 |
0.415 |
|
| 2014 |
van Beveren NJ, Schwarz E, Noll R, Guest PC, Meijer C, de Haan L, Bahn S. Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia. Translational Psychiatry. 4: e430. PMID 25158005 DOI: 10.1038/Tp.2014.52 |
0.381 |
|
| 2014 |
van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, ... ... Schwarz E, et al. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophrenia Bulletin. 40: 729-36. PMID 24860087 DOI: 10.1093/Schbul/Sbu069 |
0.373 |
|
| 2014 |
de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/J.Schres.2014.02.005 |
0.407 |
|
| 2014 |
Schwarz E, van Beveren NJ, Ramsey J, Leweke FM, Rothermundt M, Bogerts B, Steiner J, Guest PC, Bahn S. Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways. Schizophrenia Bulletin. 40: 787-95. PMID 23934781 DOI: 10.1093/Schbul/Sbt105 |
0.502 |
|
| 2014 |
Herberth M, Rahmoune H, Schwarz E, Koethe D, Harris LW, Kranaster L, Witt SH, Spain M, Barnes A, Schmolz M, Leweke MF, Guest PC, Bahn S. Identification of a molecular profile associated with immune status in first-onset schizophrenia patients. Clinical Schizophrenia & Related Psychoses. 7: 207-15. PMID 23395839 DOI: 10.3371/Csrp.Hera.020113 |
0.477 |
|
| 2014 |
Ramsey J, Schwarz E, Guest P, Van Beveren N, Leweke M, Rothermundt M, Bogerts B, Steiner J, Bahn S. EPA-1234 – Distinct molecular phenotypes in male and female schizophrenia patients European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78476-7 |
0.493 |
|
| 2014 |
de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Steiner J, Rothermundt M, Leweke FM, van Beveren NJ, Kahn RS, Bahn S. Corrigendum to "Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment" [Schizophr. Res. 154 (1-3) (2014) 23-29] Schizophrenia Research. 157: 321. DOI: 10.1016/J.Schres.2014.06.006 |
0.323 |
|
| 2013 |
Ramsey JM, Schwarz E, Guest PC, van Beveren NJ, Leweke FM, Rothermundt M, Bogerts B, Steiner J, Bahn S. Distinct molecular phenotypes in male and female schizophrenia patients. Plos One. 8: e78729. PMID 24244349 DOI: 10.1371/Journal.Pone.0078729 |
0.492 |
|
| 2013 |
Gottschalk MG, Schwarz E, Bahn S. [Biomarker research in neuropsychiatry: challenges and potential]. Fortschritte Der Neurologie-Psychiatrie. 81: 243-9. PMID 23695789 DOI: 10.1055/S-0033-1335235 |
0.413 |
|
| 2013 |
Guest PC, Martins-de-Souza D, Schwarz E, Rahmoune H, Alsaif M, Tomasik J, Turck CW, Bahn S. Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. Genome Medicine. 5: 25. PMID 23531373 DOI: 10.1186/Gm429 |
0.511 |
|
| 2013 |
Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, Rahmoune H, Bahn S. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1199-207. PMID 23183131 DOI: 10.1016/J.Euroneuro.2012.10.012 |
0.35 |
|
| 2012 |
Harris LW, Pietsch S, Cheng TM, Schwarz E, Guest PC, Bahn S. Comparison of peripheral and central schizophrenia biomarker profiles. Plos One. 7: e46368. PMID 23118852 DOI: 10.1371/Journal.Pone.0046368 |
0.506 |
|
| 2012 |
Tomasik J, Schwarz E, Guest PC, Bahn S. Blood test for schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 262: S79-83. PMID 22923188 DOI: 10.1007/S00406-012-0354-3 |
0.507 |
|
| 2012 |
Schwarz E, Guest PC, Steiner J, Bogerts B, Bahn S. Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Translational Psychiatry. 2: e82. PMID 22832819 DOI: 10.1038/Tp.2012.3 |
0.483 |
|
| 2012 |
Alsaif M, Guest PC, Schwarz E, Reif A, Kittel-Schneider S, Spain M, Rahmoune H, Bahn S. Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection. Proteomics. Clinical Applications. 6: 297-303. PMID 22641612 DOI: 10.1002/Prca.201100061 |
0.354 |
|
| 2012 |
Ernst A, Ma D, Garcia-Perez I, Tsang TM, Kluge W, Schwarz E, Guest PC, Holmes E, Sarnyai Z, Bahn S. Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission. Journal of Proteome Research. 11: 3704-14. PMID 22613019 DOI: 10.1021/Pr300197D |
0.487 |
|
| 2012 |
Jaros JA, Martins-de-Souza D, Rahmoune H, Schwarz E, Leweke FM, Guest PC, Bahn S. Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients. European Archives of Psychiatry and Clinical Neuroscience. 262: 453-5. PMID 22169887 DOI: 10.1007/S00406-011-0283-6 |
0.394 |
|
| 2012 |
Schwarz E, Guest PC, Rahmoune H, Martins-de-Souza D, Niebuhr DW, Weber NS, Cowan DN, Yolken RH, Spain M, Barnes A, Bahn S. Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 627-32. PMID 21936765 DOI: 10.3109/15622975.2011.599861 |
0.506 |
|
| 2012 |
Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, et al. Identification of a biological signature for schizophrenia in serum. Molecular Psychiatry. 17: 494-502. PMID 21483431 DOI: 10.1038/Mp.2011.42 |
0.469 |
|
| 2012 |
Li Y, Schwarz E, Bahn S, Yolken R, Niebuhr DW. High dimensional regression on serum analytes Italian Journal of Public Health. 9: e8672.1-e8672.12. DOI: 10.2427/8672 |
0.307 |
|
| 2011 |
Bahn S, Noll R, Barnes A, Schwarz E, Guest PC. Challenges of introducing new biomarker products for neuropsychiatric disorders into the market. International Review of Neurobiology. 101: 299-327. PMID 22050857 DOI: 10.1016/B978-0-12-387718-5.00012-2 |
0.456 |
|
| 2011 |
Izmailov R, Guest PC, Bahn S, Schwarz E. Algorithm development for diagnostic biomarker assays. International Review of Neurobiology. 101: 279-98. PMID 22050856 DOI: 10.1016/B978-0-12-387718-5.00011-0 |
0.421 |
|
| 2011 |
Schwarz E, VanBeveren NJ, Guest PC, Izmailov R, Bahn S. The application of multiplexed assay systems for molecular diagnostics. International Review of Neurobiology. 101: 259-78. PMID 22050855 DOI: 10.1016/B978-0-12-387718-5.00010-9 |
0.454 |
|
| 2011 |
Chan MK, Guest PC, Levin Y, Umrania Y, Schwarz E, Bahn S, Rahmoune H. Converging evidence of blood-based biomarkers for schizophrenia: an update. International Review of Neurobiology. 101: 95-144. PMID 22050850 DOI: 10.1016/B978-0-12-387718-5.00005-5 |
0.499 |
|
| 2011 |
Bahn S, Schwarz E. [Serum-based biomarkers for psychiatric disorders]. Der Nervenarzt. 82: 1395-6, 1398, 1400 p. PMID 21909807 DOI: 10.1007/S00115-011-3346-Z |
0.474 |
|
| 2011 |
Kluge W, Alsaif M, Guest PC, Schwarz E, Bahn S. Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders. Expert Review of Molecular Diagnostics. 11: 721-33. PMID 21902534 DOI: 10.1586/Erm.11.61 |
0.449 |
|
| 2011 |
Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M, van Beveren NJ, Spain M, Barnes A, Steiner J, Rahmoune H, Bahn S. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology. 36: 1092-6. PMID 21251762 DOI: 10.1016/J.Psyneuen.2010.12.018 |
0.46 |
|
| 2011 |
Schwarz E, Whitfield P, Nahnsen S, Wang L, Major H, Leweke FM, Koethe D, Lio P, Bahn S. Alterations of primary fatty acid amides in serum of patients with severe mental illness. Frontiers in Bioscience (Elite Edition). 3: 308-14. PMID 21196311 |
0.367 |
|
| 2011 |
Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Leweke MF, Guest PC, Bahn S. Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics. 11: 94-105. PMID 21182197 DOI: 10.1002/Pmic.201000291 |
0.401 |
|
| 2011 |
Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, Ruta L, Kent L, Spain M, Baron-Cohen S, Bahn S. Sex-specific serum biomarker patterns in adults with Asperger's syndrome. Molecular Psychiatry. 16: 1213-20. PMID 20877284 DOI: 10.1038/Mp.2010.102 |
0.316 |
|
| 2010 |
Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC, Rahmoune H, Pietsch S, Leweke FM, Rothermundt M, Steiner J, Koethe D, Kranaster L, Ohrmann P, Suslow T, et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomarker Insights. 5: 39-47. PMID 20520744 DOI: 10.4137/Bmi.S4877 |
0.475 |
|
| 2010 |
Wang L, Lockstone HE, Guest PC, Levin Y, Palotás A, Pietsch S, Schwarz E, Rahmoune H, Harris LW, Ma D, Bahn S. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. Journal of Proteome Research. 9: 521-7. PMID 19916557 DOI: 10.1021/Pr900867X |
0.488 |
|
| 2010 |
Levin Y, Jaros JA, Schwarz E, Bahn S. Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis. Journal of Proteomics. 73: 689-95. PMID 19896566 DOI: 10.1016/J.Jprot.2009.10.013 |
0.31 |
|
| 2010 |
Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Molecular Psychiatry. 15: 1088-100. PMID 19546861 DOI: 10.1038/Mp.2009.54 |
0.486 |
|
| 2010 |
Herberth M, Krzyszton DN, Koethe D, Craddock MR, Bulger E, Schwarz E, Guest P, Leweke FM, Bahn S. Differential effects on T-cell function following exposure to serum from schizophrenia smokers. Molecular Psychiatry. 15: 364-71. PMID 19002140 DOI: 10.1038/Mp.2008.120 |
0.374 |
|
| 2009 |
Schwarz E, Leweke FM, Bahn S, Liò P. Clinical bioinformatics for complex disorders: a schizophrenia case study. Bmc Bioinformatics. 10: S6. PMID 19828082 DOI: 10.1186/1471-2105-10-S12-S6 |
0.413 |
|
| 2009 |
Levin Y, Wang L, Ingudomnukul E, Schwarz E, Baron-Cohen S, Palotás A, Bahn S. Real-time evaluation of experimental variation in large-scale LC-MS/MS-based quantitative proteomics of complex samples. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 877: 1299-305. PMID 19056327 DOI: 10.1016/J.Jchromb.2008.11.007 |
0.3 |
|
| 2008 |
Herberth M, Schwarz E, Bahn S. Problems and promise of immunological factors as biomarkers for schizophrenia. Biomarkers in Medicine. 2: 385-95. PMID 20477392 DOI: 10.2217/17520363.2.4.385 |
0.488 |
|
| 2008 |
Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. Journal of Proteome Research. 7: 4266-77. PMID 18778095 DOI: 10.1021/Pr800188Y |
0.454 |
|
| 2008 |
Schwarz E, Bahn S. Biomarker discovery in psychiatric disorders. Electrophoresis. 29: 2884-90. PMID 18512679 DOI: 10.1002/Elps.200700710 |
0.487 |
|
| 2008 |
Schwarz E, Bahn S. Cerebrospinal fluid: identification of diagnostic markers for schizophrenia. Expert Review of Molecular Diagnostics. 8: 209-16. PMID 18366307 DOI: 10.1586/14737159.8.2.209 |
0.519 |
|
| 2008 |
Schwarz E, Bahn S. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. British Journal of Pharmacology. 153: S133-6. PMID 18193070 DOI: 10.1038/Sj.Bjp.0707658 |
0.506 |
|
| 2007 |
Schwarz E, Levin Y, Wang L, Leweke FM, Bahn S. Peptide correlation: a means to identify high quality quantitative information in large-scale proteomic studies. Journal of Separation Science. 30: 2190-7. PMID 17683046 DOI: 10.1002/Jssc.200700190 |
0.331 |
|
| 2007 |
Levin Y, Schwarz E, Wang L, Leweke FM, Bahn S. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. Journal of Separation Science. 30: 2198-203. PMID 17668910 DOI: 10.1002/Jssc.200700189 |
0.361 |
|
| 2007 |
Huang JT, McKenna T, Hughes C, Leweke FM, Schwarz E, Bahn S. CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects. Journal of Separation Science. 30: 214-25. PMID 17390615 DOI: 10.1002/Jssc.200600350 |
0.457 |
|
| Show low-probability matches. |